This federal contract award, valued at $347,981.58, was issued by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer...
This federal contract award, valued at $405,154.73, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products are delivered to VA medical...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo, to support nuclear medicine, oncology, and...
This federal contract award, valued at $801,456.68, was issued by the Veterans Integrated Service Network 21 (VISN 21) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This delivery order contract has a...
This $80,260 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This contract is not set aside for any specific...
This federal contract award is for the delivery of radiopharmaceuticals to the Veterans Integrated Service Network 8 (VISN 8), a healthcare system operated by the U.S. Department of Veterans Affairs (VA). The prime contractor is Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. that specializes in providing nuclear medicine products and services to federal agencies. The $1,665,909.11 contract is a delivery order under an Indefinite Delivery Vehicle (IDV) held by Cardinal Health 414...
This federal contract award is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an award value of $143,657.73 and a period of performance through September 29, 2024. The contract is a delivery order under an Indefinite Delivery Vehicle (IDV), which allows the VA to order a range of radiopharmaceutical products,...
This federal contract award was issued by the Veterans Integrated Service Network 23 of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $181,474.01 firm fixed-price delivery order contract is for the supply of radiopharmaceuticals, which are specialized pharmaceutical products used in nuclear medicine, oncology, and diagnostic imaging services. The contract is not set aside for any specific business type. Cardinal Health 414 has...
This is a federal contract award from the Department of Veterans Affairs (VA) to Cardinal Health, Inc., a global healthcare services and products company. The contract is for the delivery of radiopharmaceuticals for use in nuclear medicine procedures within the VA healthcare system. The contract has a firm fixed-price delivery order valued at $983,677.24 covering the period from January 18, 2022, to January 18, 2023. This is part of a larger indefinite delivery contract (IDC) valued at...
This is a firm-fixed-price delivery order contract awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21. The contract has a potential value of $406,942.11 and covers the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well...